Literature DB >> 2800921

Inhibition of human thyroid peroxidase gene expression by interleukin 1.

K Ashizawa1, S Yamashita, T Tobinaga, Y Nagayama, H Kimura, H Hirayu, M Izumi, S Nagataki.   

Abstract

We have already demonstrated the inhibitory effect of interleukin 1 on thyroglobulin gene expression. Recent availability of thyroid peroxidase cDNA has allowed us to investigate the regulation of thyroid peroxidase gene. Therefore, the regulation of thyroid peroxidase mRNA by interleukin 1 in cultured human thyrocytes was investigated. Thyrocytes dispersed from thyroid tissues from patients with Graves' disease were incubated with TSH with or without recombinant human interleukin 1. Unstimulated human thyrocytes did not contain any detectable thyroid peroxidase mRNA, however, TSH-stimulated thyrocytes expressed four thyroid peroxidase mRNA transcripts (4.0, 3.2, 2.1 and 1.7 kb, respectively). Both interleukin 1 alpha and beta inhibited TSH-induced thyroid peroxidase mRNA in a dose responsive manner; 10(3) U/1 interleukin 1 caused maximal suppression of TSH-induced thyroid peroxidase mRNA level to nearly basal levels. Interleukin 1 also inhibited cAMP analogue 8-bromo-cyclic AMP induced thyroid peroxidase mRNA level. In contrast the gamma-actin mRNA hybridization signal was not altered in control or treated cells. These results demonstrate that interleukin 1 directly inhibits TSH-induced thyroid peroxidase gene expression and provide further evidence for a paracrine role of interleukin 1 as a local inhibitor of thyroid hormone synthesis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2800921     DOI: 10.1530/acta.0.1210465

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  4 in total

Review 1.  Euthyroid Sick Syndrome and the role of cytokines.

Authors:  D A Papanicolaou
Journal:  Rev Endocr Metab Disord       Date:  2000-01       Impact factor: 6.514

2.  Early manifestation of mild cognitive impairment in B-cell non-Hodgkin's lymphoma patients receiving CHOP and rituximab-CHOP chemotherapy.

Authors:  Mohd Ashif Khan; Kamlesh Garg; Dinesh Bhurani; Nidhi Bharal Agarwal
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-08-27       Impact factor: 3.000

3.  Association between the IL1B (-511), IL1B (+3954), IL1RN (VNTR) polymorphisms and Graves' disease risk: a meta-analysis of 11 case-control studies.

Authors:  Min-Li Chen; Ning Liao; Hua Zhao; Jian Huang; Zheng-Fu Xie
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

4.  Pro inflammatory interleukins and thyroid function in Naswar (dipping tobacco) users: a case control study.

Authors:  Faiza Sajid; Samina Bano
Journal:  BMC Endocr Disord       Date:  2016-08-11       Impact factor: 2.763

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.